Recalls & Warnings December 13, 2016 Case of Hemorrhagic Stroke Linked to Redline Energy Drink A case of hemorrhagic stroke has been linked to the consumption of a single energy drink, according to a report published on October 11, 2016, in The American Journal of Emergency Medicine
It should be stored in a cool, dry place, preferably refrigerated, to maintain stability and purity
Another enzyme, known as D-2-hydroxyglutaric acid transhydrogenase, can also catalyze this conversion
Caveolae, caveolin and control of vascular tone: nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF) regulation
Common Side Effects (Generally Mild): Temporary injection site reactions (redness, slight swelling) Mild fatigue initially (as metabolism adjusts) Occasional flushing or warmth Slight changes in appetite Contraindications and Precautions: Pregnancy or breastfeeding (insufficient safety data) Active cancer (theoretical concerns about growth pathways) Severe kidney or liver disease (requires monitoring) Hypoglycemia risk (monitor if on diabetes medications) Medical Monitoring: At The Lamkin Clinic, we monitor MOTS-C patients with: Baseline metabolic labs (glucose, HbA1c, insulin, lipids) Follow-up testing at 8-12 weeks Body composition analysis Assessment of symptoms and energy levels Adjustment of other medications as metabolism improves Important: MOTS-C should only be used under the guidance of a qualified healthcare provider experienced in peptide therapy
The goal is not to take more products
